Oncocyte Corporation (NASDAQ: OCX)
$3.40
+0.0400 ( +1.19% ) 28.9K
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers.
Market Data
Open
$3.40
Previous close
$3.36
Volume
28.9K
Market cap
$43.97M
Day range
$3.26 - $3.40
52 week range
$2.08 - $4.64
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | May 22, 2024 |
4 | Insider transactions | 1 | May 22, 2024 |
4 | Insider transactions | 1 | May 22, 2024 |
8-k | 8K-related | 14 | May 15, 2024 |
10-q | Quarterly Reports | 76 | May 15, 2024 |
def | Proxies and info statements | 7 | Apr 29, 2024 |
10-k | Annual reports | 209 | Apr 16, 2024 |
4 | Insider transactions | 1 | Apr 15, 2024 |
4 | Insider transactions | 1 | Apr 15, 2024 |
4 | Insider transactions | 1 | Apr 15, 2024 |